Abstract:
A method and apparatus for handover between base stations are disclosed. The method includes: a first base station sending handover request messages to neighboring base stations (401); the neighboring base stations judging whether to accept the handover according to information in the handover request messages, and sending judgment results to the first base station through request response messages (402); the first base station determining one destination base station from the neighboring base stations which are able to accept the handover, and sending a confirmation handover message to the destination base station (403); the destination base station allocating resources for a user equipment after receiving the confirmation handover message, and sending the allocated resources to the first base station through a confirmation handover response message (404); and the first base station indicating that the user equipment hands over to the destination base station after receiving the confirmation handover response message (405).
Abstract:
The present invention provides for a resin system and coating composition suitable for direct application to metal substrates. The composition may include a phosphate functional polyester. The polyester may be an unsaturated polyester polyol. The coating composition may further include a suitable curing agent, such as an isocyanate or melamine. The composition can be applied through traditional application equipment onto a variety of metal substrates and cures to an acceptable surface for further processing, such as top coating with basecoat and clearcoat.
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic protein family members, compositions containing the compounds and uses of the compounds for preparing medicaments for treating diseases during which occurs expression one or more than one of an anti-apoptotic protein family member.
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic protein family members, compositions containing the compounds and uses of the compounds for preparing medicaments for treating diseases during which occurs expression one or more than one of an anti-apoptotic protein family member.
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Abstract:
Compounds which inhibit the activity of anti-apoptotic family protein members, compositions containing the compounds and methods of treating diseases during which occur expression one or more than one of an anti-apoptotic family protein member are disclosed.
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic protein family members, compositions containing the compounds and uses of the compounds for preparing medicaments for treating diseases during which occurs expression one or more than one of an anti-apoptotic protein family member.
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Abstract:
Compounds which inhibit the activity of anti-apoptotic Mcl-1 protein, compositions containing the compounds and methods of treating diseases during which are expressed the Mcl-1 protein are disclosed.
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic protein family members, compositions containing the compounds and uses of the compounds for preparing medicaments for treating diseases during which occurs expression one or more than one of an anti-apoptotic protein family member.